Jaydess

Levonorgestrel, the active ingredient in Jaydess, is a progestin presented as an intrauterine system (IUS) for intrauterine use. It prevents pregnancy by providing continuous hormonal contraception for women of reproductive age. GNH USA supplies Jaydess as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Jaydess is a levonorgestrel‑based intrauterine system that acts within the hormonal contraceptive class. It is indicated for: - Contraception: provides long‑term prevention of pregnancy when inserted in the uterus. - Menstrual bleeding control: may reduce the volume and duration of menstrual bleeding. - Endometrial protection: helps maintain a thin endometrial lining, lowering the risk of hyperplasia.

Side effects are reported with intrauterine levonorgestrel systems and vary in frequency.

Common Side Effects: - Irregular bleeding or spotting, especially during the first months after insertion. - Reduced menstrual blood loss or amenorrhea. - Pelvic or abdominal discomfort. - Headache. - Breast tenderness. - Mood changes or mild depressive symptoms.

Serious or Rare Side Effects: - Uterine perforation during insertion. - Pelvic inflammatory disease. - Ectopic pregnancy if contraception fails. - Severe allergic reaction (anaphylaxis). - Ovarian cyst formation. - Deep vein thrombosis or other thromboembolic events.

Before using Jaydess, consider the following precautions: - Pregnancy status: ensure the patient is not already pregnant before insertion. - Uterine abnormalities: avoid use in patients with known uterine fibroids, congenital anomalies, or active infection. - Recent pelvic infection: postpone insertion until infection resolves. - Breastfeeding: discuss benefits and risks with a healthcare professional. - Smoking: advise cessation, especially in women over 35, due to increased cardiovascular risk. - Store below 25°C: keep in the original packaging, protect from moisture and direct sunlight.

Levonorgestrel IUS may interact with other medicines that affect hormonal balance or uterine environment.

Major Interactions (Avoid): - Enzyme inducers such as rifampin, carbamazepine, phenytoin, and griseofulvin, which can reduce levonorgestrel effectiveness. - Antifungal agents like ketoconazole that may increase systemic hormone levels.

Moderate Interactions (Monitor Closely): - Anticoagulants (e.g., warfarin) – monitor bleeding risk. - Antidepressants (SSRIs) – may affect mood changes. - Herbal supplements containing St. John’s wort – possible reduction in contraceptive efficacy.